针对表面受体的基于蛋白质的纳米载体用于药物输送:癌症治疗的进展
Panneerselvam Theivendren1, Parasuraman Pavadai2, Suganthan Veerachamy3
1Department of Pharmaceutical Chemistry & Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology & Advanced Studies, Pallavaram, Chennai 600117, India.
Nanotechnology
|January 23, 2025
概括
基于蛋白质的纳米载体为癌症治疗提供了有针对性的方法,改善了药物输送和减少副作用. 这些生物相容纳米颗粒通过选择性向癌细胞来提高治疗效率,最大限度地减少对健康组织的伤害.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 在瘤学瘤学.
背景情况:
- 传统化疗面临的挑战包括缺乏特异性,副作用和耐药性.
- 基于蛋白质的纳米载体是癌症治疗中向药物输送的有希望的替代品.
研究的目的:
- 探索基于蛋白质的纳米载体在向癌症治疗中的潜力.
- 突出这些纳米载体在传统化疗中的优势.
主要方法:
- 设计基于的纳米载体,具有生物相容性和生物降解性质.
- 利用向性连接物 (抗体,氨基酸,维生素) 进行特定的癌细胞积累.
- 利用蛋白质骨干的自然*in vivo*降解来提高安全性.
主要成果:
- 基于蛋白质的纳米载体在癌细胞中显示选择性药物积累,减少非向效应和全身毒性.
- 蛋白质纳米载体的固有生物降解性比合成材料具有优势.
- 有针对性的治疗可以提高治疗效果,同时尽量减少副作用.
结论:
- 基于蛋白质的纳米载体显示出通过向药物输送来改善癌症管理的巨大潜力.
- 为了广泛的临床应用,需要在蛋白质工程,药物加载和向方面进行进一步的研究.
- 这些先进的纳米粒子可能会导致更个性化,更有针对性,更安全的癌症疗法.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K